Current status of MRI and ultrasound fusion software platforms for guidance of prostate biopsies - Abstract

Prostate MRI is currently the best diagnostic imaging method for detecting prostate cancer.

Magnetic Resonance Imaging-Ultrasound (MRI/US) fusion allows the sensitivity and specificity of MRI to be combined with real time capabilities of transrectal ultrasound (TRUS). Multiple approaches and techniques exist for MRI/US fusion and include (1) direct "in bore" MR biopsies, (2) cognitive fusion, and (3) MRI/US fusion via software-based image co-registration platforms.

Written by:
Logan JK, Rais-Bahrami S, Turkbey B, Gomella A, Amalou H, Choyke PL, Wood BJ, Pinto PA.   Are you the author?
Urologic Oncology Branch, National Cancer Institute, National Institutes of Health.

Reference: BJU Int. 2013 Dec 3. Epub ahead of print.
doi: 10.1111/bju.12593


PubMed Abstract
PMID: 24298917

UroToday.com Prostate Cancer Section